Evidence map›Paper›PMID 38460178›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

Matrix Metalloproteinase-Responsive Hydrogel with On-Demand Release of Phosphatidylserine Promotes Bone Regeneration Through Immunomodulation.

Mingjin Zhang, Tingting Yu, Jing Li, Huichun Yan, Liang Lyu, Yi Yu, Gengchen Yang, Ting Zhang, Yanheng Zhou, Xing Wang and 1 more

Open access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Cell-Free DNA-Based Theranostics for Inflammatory Disorders.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Mingjin ZhangDepartment of Orthodontics, Peking University School and Hospital of Stomatology, Beijing, 100081, China.
Tingting YuDepartment of Orthodontics, Peking University School and Hospital of Stomatology, Beijing, 100081, China.
Jing LiDepartment of Orthodontics, Peking University School and Hospital of Stomatology, Beijing, 100081, China.
Huichun YanDepartment of Orthodontics, Peking University School and Hospital of Stomatology, Beijing, 100081, China.
Liang LyuDepartment of Orthodontics, Peking University School and Hospital of Stomatology, Beijing, 100081, China.
Yi YuDepartment of Orthodontics, Peking University School and Hospital of Stomatology, Beijing, 100081, China.
Gengchen YangDepartment of Orthodontics, Peking University School and Hospital of Stomatology, Beijing, 100081, China.
Ting ZhangDepartment of Orthodontics, Peking University School and Hospital of Stomatology, Beijing, 100081, China.
Yanheng ZhouDepartment of Orthodontics, Peking University School and Hospital of Stomatology, Beijing, 100081, China.
Xing WangBeijing National Laboratory for Molecular Sciences, Institute of Chemistry, Chinese Academy of Sciences, Beijing, 100190, China.ORCID 0000-0003-3926-1999
Dawei LiuDepartment of Orthodontics, Peking University School and Hospital of Stomatology, Beijing, 100081, China.ORCID 0000-0002-7625-4600
Peking University · CNChinese Academy of Sciences · CN

Funding

Beijing Natural Science Foundation L222116China Oral Health Foundation A2021057Key R & D Plan of Ningxia Hui Autonomous Region 2020BCG01001National Key R&D Program of China 2022YFA1206100National Natural Science Foundation of China 51973226National Natural Science Foundation of China 52373123National Natural Science Foundation of China 52373162National Natural Science Foundation of China 62076011National Natural Science Foundation of China 81970909National Natural Science Foundation of China 82271009National Program for Multidisciplinary Cooperative Treatment on Major Diseases PKUSSNMP202020New Clinical Technology Fund of Peking University School of Stomatology PKUSSNCT-20A07Young Elite Scientist Sponsorship Program by CAST 2021QNRC001Youth Innovation Promotion Association CAS 2019031
6 · The paper itself

Abstract

Inflammation-responsive hydrogels loaded with therapeutic factors are effective biomaterials for bone tissue engineering and regenerative medicine. In this study, a matrix metalloproteinase (MMP)-responsive injectable hydrogel is constructed by integrating an MMP-cleavable peptide (pp) into a covalent tetra-armed poly-(ethylene glycol) (PEG) network for precise drug release upon inflammation stimulation. To establish a pro-regenerative environment, phosphatidylserine (PS) is encapsulated into a scaffold to form the PEG-pp-PS network, which could be triggered by MMP to release a large amount of PS during the early stage of inflammation and retain drug release persistently until the later stage of bone repair. The hydrogel is found to be mechanically and biologically adaptable to the complex bone defect area. In vivo and in vitro studies further demonstrated the ability of PEG-pp-PS to transform macrophages into the anti-inflammatory M2 phenotype and promote osteogenic differentiation, thus, resulting in new bone regeneration. Therefore, this study provides a facile, safe, and promising cell-free strategy on simultaneous immunoregulation and osteoinduction in bone engineering.

Indexed as

Bone RegenerationHydrogelsMatrix MetalloproteinasesPhosphatidylserinesAnimalsBiocompatible MaterialsDisease Models, AnimalImmunomodulationMiceModels, AnimalOsteogenesisPolyethylene GlycolsTissue EngineeringTissue ScaffoldsBiocompatible MaterialsHydrogelsMatrix MetalloproteinasesPhosphatidylserinesPolyethylene Glycolsbone regenerationhydrogelsmacrophage regulationmatrix‐metalloproteinase‐responsivephosphatidylserine (PS)

Identifiers

PMID38460178
PMCPMC11132073
OpenAlexW4392619299

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.